Price Alert

Rapid Micro Biosystems In... (RPID)

NASDAQ: RPID · Real-Time Price · USD

2.66

0.04 (1.53%)

At close: Aug 18, 2025, 3:59 PM

1.53% (1D)

Bid	2.5
Market Cap	117.11M
Revenue (ttm)	29.64M
Net Income (ttm)	-44.83M
EPS (ttm)	-1
PE Ratio (ttm)	-2.66
Forward PE	-4
Analyst	Buy

Ask	2.78
Volume	44,328
Avg. Volume (20D)	96,635
Open	2.60
Previous Close	2.62
Day's Range	2.59 - 2.75
52-Week Range	0.80 - 4.50
Beta	1.33

About RPID

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol RPID

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for RPID stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Rapid Micro Biosystems has released their quartely earnings on Aug 12, 2025:

Revenue of $7.26M exceeds estimates by $102K, with 9.73% YoY growth.

EPS of -0.27 misses estimates by -0.01, with 6.90% YoY growth.

Next Earnings Release

Rapid Micro Biosystems Inc. is scheduled to release its earnings on Oct 31, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

6 days ago

-17.79%

Rapid Micro Biosystems shares are trading lower fo... Unlock content with Pro Subscription

3 months ago

+25.71%

Rapid Micro Biosystems shares are trading higher after the company reported better-than-expected Q1 financial results.

News

6 days ago · zacks.com

Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Misses Revenue Estimates

Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.29 per share a year ago.

6 days ago · seekingalpha.com

Rapid Micro Biosystems, Inc. (RPID) Q2 2025 Earnings Call Transcript

Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q2 2025 Earnings Conference Call August 12, 2025 8:30 AM ET Company Participants Michael Beaulieu - Vice President of Investor Relations & Corporate Communi...

3 weeks ago · seekingalpha.com

Rapid Micro Biosystems: Benefiting From Partnership With Merck; Initiating With 'Buy'

Initiating Rapid Micro Biosystems at 'buy' with $4.60 fair value, driven by strong growth potential in automated microbial quality control market. Growth Direct platform offers clear advantages over m...